What's Happening In The Dental Practice Market? with Luke Moore and Phil Kolodynski [CPD Available]
カートのアイテムが多すぎます
カートに追加できませんでした。
ウィッシュリストに追加できませんでした。
ほしい物リストの削除に失敗しました。
ポッドキャストのフォローに失敗しました
ポッドキャストのフォロー解除に失敗しました
-
ナレーター:
-
著者:
概要
Check if your dental practice qualifies for capital allowances here >>> https://www.dentistswhoinvest.com/chris-lonergan
———————————————————————
UK Dentists: Collect your verifiable CPD for this episode here >>> https://courses.dentistswhoinvest.com/smart-money-members-club
———————————————————————
Want a clear read on where dental practice sales are heading in 2026? We pull the market apart with hard data and lived deal flow: why lenders are back competing, how deposit requirements and margins over base have shifted, and what that means for first‑time buyers who were frozen out when stress tests sat at 9 percent. The short version: activity is strong, but the edge now comes from clean operations, bankable income, and smarter deal structures rather than chasing the highest multiple.
We unpack the corporate reset and the rise of microconsolidators. Many large groups paused to protect EBITDA and trim head office cost under inflation pressure and softer private demand. In their wake, tier‑three and tier‑four buyers with lighter structures and cheaper debt have moved fast, often winning not on price but on certainty: more cash on completion, fewer strings, and realistic transition expectations. If you’re selling, we show how net proceeds after CGT, risk, and deferred hurdles can make a slightly lower headline number the better outcome.
On the valuation front, NHS and mixed practices are regaining heat with recruitment stabilising in major cities and UDA tweaks improving deliverability. Private remains attractive, but associate percentages, lab costs, and marketing spend demand tighter control. We dive into the emerging shift in associate remuneration—transparent lab splits, sliding scales tied to value, and fair cost sharing—to protect margins without endless patient fee hikes. We also flag a key policy watch: potential curbs on non‑competes that could change how goodwill is protected, pushing owners to build moats through brand, patient plans, and clinician engagement.
———————————————————————
Disclaimer: All content on this channel is for education purposes only and does not constitute an investment recommendation or individual financial advice. For that, you should speak to a regulated, independent professional. The value of investments and the income from them can go down as well as up, so you may get back less than you invest. The views expressed on this channel may no longer be current. The information provided is not a personal recommendation for any particular investment. Tax treatment depends on individual circumstances and all tax rules may change in the future. If you are unsure about the suitability of an investment, you should speak to a regulated, independent professional. Investment figures quoted refer to simulated past performance and that past performance is not a reliable indicator of future results/performance.
Send us a text